Diagnosis and management of immune checkpoint inhibitor-associated adrenal insufficiency: A single-institution experience
Journal of Oncology Pharmacy Practice
Published online on April 15, 2025
Abstract
Journal of Oncology Pharmacy Practice, Ahead of Print.
BackgroundImmune checkpoint inhibitor (ICI) therapy has revolutionized the treatment of various malignancies. Unfortunately, ICI therapy has been associated with multiple immune related adverse events (irAEs) resulting in organ damage. One rare, but ...
BackgroundImmune checkpoint inhibitor (ICI) therapy has revolutionized the treatment of various malignancies. Unfortunately, ICI therapy has been associated with multiple immune related adverse events (irAEs) resulting in organ damage. One rare, but ...